IRTC - NASDAQ
iRhythm Technologies, Inc.
$104.56
+1.5%iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.
At a Glance
Live SnapshotiRhythm Technologies, Inc. Cash Conversion Engine
Cash Flow Quality Analysis
FCF Conversion Rate
Negative free cash flow despite positive earnings raises concerns about cash generation ability or heavy capital requirements.
CapEx Intensity
Capital-intensive operations require significant reinvestment. Monitor whether CapEx is maintenance or growth-oriented.
FCF Growth Trend
Strong FCF growth demonstrates improving cash generation and business momentum. Positive signal for sustainability.
Working Capital Impact
Significant working capital drain. Growth may be consuming cash through inventory buildup or receivables extension—monitor closely.
Cash Flow Quality Insight
Working capital strain: Significant cash tied up in operations. Monitor receivables collection, inventory turns, and payment terms to optimize cash conversion cycle.
iRhythm Technologies, Inc. Cash Flow Statement
IRTC • NASDAQ
| iRhythm Technologies, Inc. Cash Flow Statement | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
OPERATING ACTIVITIES | |||||||||||||
-44.6M | 0.0 | -123.4M | -116.2M | -101.4M | -43.8M | -54.6M | -48.3M | -29.4M | -20.9M | -22.8M | -15.8M | -13.6M | |
0.0 | 0.0 | 22.1M | 19.6M | 16.6M | 6.9M | 3.4M | 2.3M | 1.6M | 568K | 492K | 242K | 150K | |
0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 31.9M | 23.8M | 17.4M | 9.1M | 4.7M | 10K | 408K | 0.0 | |
0.0 | 0.0 | 77.2M | 57.7M | 54.5M | 41.5M | 26.2M | 16.3M | 10.1M | 1.9M | 1.4M | 828K | 772K | |
217.1M | 102.5M | 76M | 81.3M | 38.7M | 6M | 9M | -2.9M | 1.8M | 3.9M | 227K | 402K | 1.5M | |
(0.0) | (923K) | (1.1M) | (287K) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | |
-91.7M | -99.1M | -102M | -65.5M | -46.2M | -56.2M | -29.7M | -13.9M | -8.1M | -6.7M | 2.7M | -1.7M | -712K | |
80.9M | 3.4M | -50.1M | -23M | -37.8M | -13.8M | -21.9M | -29.1M | -14.9M | -16.7M | -18M | -15.6M | -11.8M | |
INVESTING ACTIVITIES | |||||||||||||
-46.3M | -33.9M | -40.4M | -29.8M | -28.1M | -13.6M | -20.5M | -5.2M | -3.6M | -2.8M | -1.8M | -539K | -452K | |
(0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (118.8M) | (68.8M) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | |
-468.4M | (0.0) | -167.3M | -188.6M | -122.2M | -277.5M | -165.9M | -93.2M | -129.8M | -65.4M | (0.0) | (0.0) | (0.0) | |
237.7M | 0.0 | 206.5M | 166M | 255.5M | 158.7M | 97.1M | 132.5M | 98.7M | 0.0 | 0.0 | 0.0 | 0.0 | |
0.0 | -89M | 0.0 | 0.0 | 0.0 | -118.8M | -68.8M | 39.3M | 91K | -65.4M | 0.0 | 0.0 | 0.0 | |
-277.1M | -123M | -1.2M | -52.4M | (105.3M) | -132.4M | -89.3M | (34.1M) | -34.6M | -68.2M | -1.8M | -539K | -452K | |
FINANCING ACTIVITIES | |||||||||||||
12.6M | -25M | 0.0 | 0.0 | 8.9M | 206M | 107.4M | 0.0 | 6.4M | 114.4M | 309K | 0.0 | 0.0 | |
0.0 | 619.8M | 0.0 | 13.5M | -11.7M | -1.9M | 0.0 | 3.5M | 0.0 | 0.0 | 24.1M | 405K | 2.1M | |
(0.0) | -25M | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | -3.9M | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | |
0.0 | -83.5M | 8.8M | 13.2M | -25.9M | 10.2M | 4.2M | 2.8M | 142K | -3.2M | 12.3M | 50K | 12.4M | |
12.6M | 511.4M | 8.8M | 26.7M | -28.6M | 214.3M | 111.6M | 6.3M | 6.5M | 111.3M | 36.4M | 17.7M | 14.5M | |
CASH FLOW SUMMARY | |||||||||||||
1K | -6K | -169K | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
-183.6M | 391.8M | -42.7M | -48.7M | 38.9M | 68.2M | 439K | 11.4M | -43M | 26.4M | 16.6M | 1.5M | 2.2M | |
419.6M | 36.2M | 78.8M | 127.6M | 88.6M | 20.5M | 20M | 8.7M | 51.6M | 25.2M | 8.6M | 7.1M | 4.9M | |
236M | 428M | 36.2M | 78.8M | 127.6M | 88.6M | 20.5M | 20M | 8.7M | 51.6M | 25.2M | 8.6M | 7.1M | |
34.5M | -30.6M | -90.5M | -52.8M | -65.8M | -27.3M | -42.3M | -34.2M | -18.5M | -19.4M | -19.8M | -16.2M | -12.3M |
SEC Filings
IRTC - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
8-K 8-K 2026 N/A | May 28, 2026 | May 27, 2026 | 2026 | |
10-Q 10-Q 2026 Q1 Q1 | April 30, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 30, 2026 | April 30, 2026 | 2026 | |
DEF 14A DEF 14A 2025 N/A | April 17, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | April 01, 2026 | March 30, 2026 | 2026 | |
8-K 8-K 2026 N/A | March 12, 2026 | March 12, 2026 | 2026 | |
10-K 10-K 2025 FY FY | February 19, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | February 19, 2026 | February 19, 2026 | 2026 | |
8-K 8-K 2025 N/A | November 12, 2025 | November 12, 2025 | 2025 | |
8-K 8-K 2025 N/A | October 30, 2025 | October 30, 2025 | 2025 |
Related Guides
Continue your IRTC research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.